Second Phase II trial of ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.

Trial Profile

Second Phase II trial of ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.

Planning
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs ZYN 001 (Primary)
  • Indications Fibromyalgia; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Mar 2017 New trial record
    • 27 Mar 2017 This trial is expected to begin in the second half of 2017, according to a Zynerba Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top